Project Grant R01AG100135
- Federal Grant Award Summary Yale University received a $380,748 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 1, 2025, through May 31, 2028. This research initiative investigates the immunological mechanisms underlying exercise's beneficial effects on skeletal muscle aging. The project will deliver scientific research and analysis examining how mechanical stress-induced inflammation in muscle stromal cells and...
- Federal Grant Award Summary Yale University received a $746,160 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded on March 20, 2026, with a completion date of February 28, 2031. The research project, titled "Impact of Peripheral Inflammation on Microglia and Neurons in Aging," will be conducted at Yale's New Haven, Connecticut facility. This award supports biomedical research aimed at understanding the mechanisms by which...
- Federal Project Grant Award Summary Yale University received a $461,146 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded on May 15, 2025, with completion targeted for April 30, 2027. The award funds research investigating the dysregulation of cortical astrocytes in Alzheimer's disease (AD) models. The primary deliverable is novel scientific research employing advanced mesoscopic imaging techniques to longitudinally measure...
- Federal Grant Award Summary Yale University received a $461,311 Project Grant from the National Institute on Aging (CFDA 93.866, Aging Research program) effective May 1, 2026 through April 30, 2028 to conduct research on vascular smooth muscle aging and the epigenetic clock. The research will investigate how epigenetic alterations, particularly DNA methylation changes, contribute to vascular smooth muscle cell (SMC) dysfunction and accelerated biological aging in the arterial wall—a key driver...
- Federal Project Grant Summary Albert Einstein College of Medicine received a $462,000 Project Grant award dated August 15, 2025, from the National Institute on Aging under the Aging Research program (CFDA 93.866) to conduct research on thymus function regulation and age-related decline. The project, scheduled for completion by July 31, 2027, will deliver comprehensive scientific research outputs investigating the role of the sympathetic nervous system in thymic involution. The primary...
- Federal Grant Award Summary Yale University received a $921,822 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded June 9, 2025, with completion targeted for May 31, 2027. The grant funds research investigating lysosomal regulation and functions of Tank-Binding Kinase 1 (TBK1) in neurodegenerative diseases, specifically amyotrophic lateral sclerosis and frontotemporal dementia. The research will deliver molecular and mechanistic insights...
- Federal Project Grant Award Summary Yale University received a $461,313 Project Grant award from the National Institute on Aging (Aging Research program, CFDA 93.866) effective June 1, 2025 through May 31, 2027. The grant supports research investigating the role of cysteine string protein alpha (CSPα) in presynaptic autophagy and its relationship to neurodegeneration. The project will generate scientific knowledge products including characterization of synaptic vesicles, autophagosomes, and...
- Federal Grant Award Summary Yale University received a $461,146 Project Grant from the National Institute on Aging (CFDA 93.866 – Aging Research program) awarded May 15, 2025, with a completion date of April 30, 2027. The award funds research targeting isoform-specific Fibroblast Growth Factor Receptor (FGFR) signaling in Idiopathic Pulmonary Fibrosis (IPF), a chronic progressive lung disease predominantly affecting adults over 65 years of age. The research addresses a significant clinical need,...
- Federal Grant Award Summary The National Institute on Aging awarded a $708,137 Project Grant to New York University School of Medicine (Award Date: February 1, 2026; Completion Date: January 31, 2030) under the Aging Research program (CFDA 93.866) to develop and validate advanced technologies for probing the biophysical properties of aging cells. The project focuses on creating Genetically Encoded Multimeric Particles (GEMs)—self-assembling, genetically encoded probe particles that enable...
- Federal Project Grant Award Summary Yale University received a $735,631 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective April 1, 2026 through March 31, 2031. The award supports fundamental and translational research investigating the origin, development, and functional properties of a distinct population of CX3CR1+ neutrophils—specialized immune cells that differ from...
Yale University received a $681,277 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded May 15, 2026, with completion targeted for April 30, 2031. The research project, titled "Cell Size Inheritance and Innate Immune Memory," investigates the mechanisms by which immune cells enlarge without triggering senescence—a pathological state characterized by irreversible cell cycle arrest associated with aging. The primary deliverables include scientific research findings on the FBP17 endocytic protein pathway, which regulates cell size setpoint in mast cells and macrophages while preserving proliferative capacity. The research utilizes single-cell microchannel systems to monitor real-time cell growth and quantify size homeostasis, with particular focus on monocyte cell size variations in aged versus young mice and the relationship between FBP17 expression, cell enlargement, and exhaustion-like immune memory states. The project addresses a critical gap in understanding how enlarged innate immune cells maintain immune surveillance without transitioning into senescence, with implications for sepsis detection and age-related immune dysfunction. Research outputs will include peer-reviewed publications, experimental data characterizing the adder growth mechanism in FBP17-deficient cells, and mechanistic insights into transgenerational cellular memory. These findings are intended to advance NIA's mission of understanding aging processes and age-related diseases through biomedical research, potentially informing diagnostic and therapeutic approaches for age-related immune compromise and infection-related pathologies.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $681.3k | 5/11/26 |